艾科ACON品牌怎么样 申请店铺

我要投票 艾科ACON在血糖仪行业中的票数:368 更新时间:2025-07-31
艾科ACON是哪个国家的品牌?「艾科ACON」是艾康生物技术(杭州)有限公司旗下著名品牌。该品牌发源于浙江省杭州市,在1995年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力艾科ACON品牌出海!将品牌入驻外推网,定制艾科ACON品牌推广信息,可以显著提高艾科ACON产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

艾科ACON怎么样

成立于1995年,十大血糖仪品牌,浙江省著名商标,专注于体外诊断试剂/医疗器械/医疗电子领域,国内颇大的生物诊断产品产业化基地


艾康生物技术(杭州)有限公司,是留美华人创办的外商独资生物技术公司,公司成立于1995年,是陆续通过美国FDA、欧洲CE、 ISO13485三个认证的生物诊断公司。生产管理严格按照国际质量管理体系运行,保障了产品的高质量。

艾康依托中美两地人才技术优势,在生物诊断领域已形成完善的研发、生产和销售的产业化体系,为公司的可持续发展提供了强大的动力。

艾康产品覆盖体外诊断试剂、医疗器械、医疗电子三个产业,以高科技产品服务客户为中心,整合生物技术(BT)和电子信息技术(IT),通过研制方便的临床检测产品来促进对疾病的诊断,专注于为用户提供更方便、更丰富的床边诊断产品。公司已成功开发了艾科系列血糖仪、尿液分析仪、干式生化分析仪、血红蛋白分析仪、血脂分析仪等医疗器械及相应检测试剂、PCR检测试剂、酶联免疫检测试剂、胶体金检测试剂等100多种快速诊断产品,获得80项中国SFDA医疗器械证书,80个产品的365个型号获得欧洲CE认证,产品畅销世界140多个国家和地区,成为全球颇大的生物诊断产品产业化基地之一。


Founded in 1995, it is one of the top ten brand of blood glucose meter, a famous brand in Zhejiang Province, focusing on in vitro diagnostic reagents / medical devices / medical electronics. Aikang Biotechnology (Hangzhou) Co., Ltd., a fairly large industrial base of biological diagnostic products in China, is a foreign-funded biotechnology company founded by Chinese living in the United States. Founded in 1995, it has successively passed FDA, CE and iso1348 5 three certified diagnostic companies. Production management operates in strict accordance with the international quality management system, ensuring the high quality of products. Relying on the technological advantages of talents in China and the United States, Aikang has formed a complete industrial system of R & D, production and sales in the field of biological diagnosis, which provides a strong driving force for the sustainable development of the company. Aikang products cover three industries: in vitro diagnostic reagents, medical devices and medical electronics. With high-tech products serving customers as the center, it integrates Biotechnology (BT) and electronic information technology (it), promotes the diagnosis of diseases through the development of convenient clinical detection products, and focuses on providing more convenient and rich bedside diagnostic products for users. The company has successfully developed more than 100 kinds of rapid diagnosis products, such as Aike series blood glucose analyzer, urine analyzer, dry biochemical analyzer, hemoglobin analyzer, blood lipid analyzer and corresponding detection reagents, PCR detection reagents, enzyme-linked immunosorbent detection reagents, colloidal gold detection reagents, etc., and has obtained 80 Chinese SFDA medical device certificates, and 365 models of 80 products have obtained European CE Certification, the products sell well in more than 140 countries and regions in the world, and become one of the large industrial bases of biological diagnosis products in the world.

本文链接: https://brand.waitui.com/2ff437b72.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前多数上涨,Meta涨0.9%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,Meta涨0.9%,英伟达涨0.72%,微软涨0.24%,亚马逊涨0.21%,特斯拉涨0.15%,奈飞涨0.1%;苹果跌0.19%,谷歌跌0.14%。

2小时前

热门中概股美股盘前多数下跌,新东方跌超10%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,新东方跌超10%,蔚来、小鹏汽车跌超2%,理想汽车、富途控股跌超1%;名创优品涨超1%,百度涨0.29%。

2小时前

特朗普:第二季度GDP数据远好于预期

据外媒报道,特朗普表示,第二季度GDP数据刚刚公布,远好于预期。(第一财经)

2小时前

普拉达上半年净营收27.4亿欧元,同比增加8%

普拉达7月30日公布2025年上半年财报显示,净营收27.4亿欧元,同比增加8%,净利润3.86亿欧元。(界面)

2小时前

三星医疗:子公司中标2955.5万美元美国Nexgrid智能电表框架项目

36氪获悉,三星医疗发布公告,公司下属控股墨西哥子公司南森墨西哥中标美国Nexgrid智能电表框架项目,合同金额总计2955.5万美元,约合2.12亿人民币,占公司2024年度经审计营业收入的1.45%。

2小时前

本页详细列出关于艾科ACON的品牌信息,含品牌所属公司介绍,艾科ACON所处行业的品牌地位及优势。
咨询